198 related articles for article (PubMed ID: 24184238)
1. Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry).
Maddox TM; Chan PS; Spertus JA; Tang F; Jones P; Ho PM; Bradley SM; Tsai TT; Bhatt DL; Peterson PN
J Am Coll Cardiol; 2014 Feb; 63(6):539-46. PubMed ID: 24184238
[TBL] [Abstract][Full Text] [Related]
2. Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.
Figueroa JF; Blumenthal DM; Feyman Y; Frakt AB; Turchin A; Doros G; Gao Q; Song Y; Joynt Maddox KE
JAMA Cardiol; 2019 Mar; 4(3):265-271. PubMed ID: 30785590
[TBL] [Abstract][Full Text] [Related]
3. Outpatient Prescription Practices in Patients with Atrial Fibrillation (From the NCDR PINNACLE Registry).
Hsu JC; Reynolds MR; Song Y; Doros G; Lubitz SA; Gehi AK; Turakhia MP; Maddox TM
Am J Cardiol; 2021 Sep; 155():32-39. PubMed ID: 34284863
[TBL] [Abstract][Full Text] [Related]
4. Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program.
Peterson PN; Chan PS; Spertus JA; Tang F; Jones PG; Ezekowitz JA; Allen LA; Masoudi FA; Maddox TM
Circ Heart Fail; 2013 Nov; 6(6):1132-8. PubMed ID: 24130004
[TBL] [Abstract][Full Text] [Related]
5. Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease: Implications for Value-Based Payment.
Wadhera RK; Bhatt DL; Kind AJH; Song Y; Williams KA; Maddox TM; Yeh RW; Dong L; Doros G; Turchin A; Joynt Maddox KE
Circ Cardiovasc Qual Outcomes; 2020 Apr; 13(4):e005977. PubMed ID: 32228065
[TBL] [Abstract][Full Text] [Related]
6. Provider-Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry.
Sardana M; Tang Y; Magnani JW; Ockene IS; Allison JJ; Arnold SV; Jones PG; Maddox TM; Virani SS; McManus DD
J Am Heart Assoc; 2019 Jul; 8(13):e011412. PubMed ID: 31248329
[TBL] [Abstract][Full Text] [Related]
7. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
[TBL] [Abstract][Full Text] [Related]
8. Treatment differences by health insurance among outpatients with coronary artery disease: insights from the national cardiovascular data registry.
Smolderen KG; Spertus JA; Tang F; Oetgen W; Borden WB; Ting HH; Chan PS
J Am Coll Cardiol; 2013 Mar; 61(10):1069-75. PubMed ID: 23375933
[TBL] [Abstract][Full Text] [Related]
9. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
[TBL] [Abstract][Full Text] [Related]
10. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
[TBL] [Abstract][Full Text] [Related]
11. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
[TBL] [Abstract][Full Text] [Related]
12. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry.
Virani SS; Maddox TM; Chan PS; Tang F; Akeroyd JM; Risch SA; Oetgen WJ; Deswal A; Bozkurt B; Ballantyne CM; Petersen LA
J Am Coll Cardiol; 2015 Oct; 66(16):1803-1812. PubMed ID: 26483105
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Provider and Practice Volume to Performance Measure Adherence for Coronary Artery Disease, Heart Failure, and Atrial Fibrillation: Results From the National Cardiovascular Data Registry.
Fleming LM; Jones P; Chan PS; Andrei AC; Maddox TM; Farmer SA
Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):48-54. PubMed ID: 26646817
[TBL] [Abstract][Full Text] [Related]
14. The use of medications in the secondary prevention of coronary artery disease in the Asian region.
Dalal J; Low LP; Van Phuoc D; Abdul Rahman AR; Reyes E; Ann Soenarta A; Tomlinson B
Curr Med Res Opin; 2015 Mar; 31(3):423-33. PubMed ID: 25629795
[TBL] [Abstract][Full Text] [Related]
15. Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry).
Khalid U; Bandeali S; Jones PG; Virani SS; Hira R; Hamzeh I; Chan PS; Kleiman NS; Lakkis N; Alam M
Am J Cardiol; 2019 Dec; 124(12):1807-1812. PubMed ID: 31668345
[TBL] [Abstract][Full Text] [Related]
16. In-hospital prescriptions of secondary-prevention medications for post-acute coronary syndrome patients in South Korea
.
Kang HB; Choi M; Yoon SG; Cho YS; Je NK
Int J Clin Pharmacol Ther; 2018 Jan; 56(1):1-11. PubMed ID: 29168689
[TBL] [Abstract][Full Text] [Related]
17. Secondary prevention for coronary artery disease: are we following the guidelines?
Syed IA; Riaz A; Ryan A; Reilly MO
Ir J Med Sci; 2010 Dec; 179(4):535-7. PubMed ID: 20676796
[TBL] [Abstract][Full Text] [Related]
18. Applying the evidence in coronary disease secondary prevention: a call to action.
Newby LK
J Am Coll Cardiol; 2014 Feb; 63(6):547-8. PubMed ID: 24184241
[No Abstract] [Full Text] [Related]
19. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
20. Difference in Medication Adherence Between Patients Prescribed a 30-Day Versus 90-Day Supply After Acute Myocardial Infarction.
Rymer JA; Fonseca E; Bhandary DD; Kumar D; Khan ND; Wang TY
J Am Heart Assoc; 2021 Jan; 10(1):e016215. PubMed ID: 33342227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
